Brain Aging and Behavior Section

The overall goal of the Brain Aging and Behavior Section (BABS) is to improve cognitive outcomes with aging. Section investigators conduct longitudinal cognitive, neuroimaging, and fluid biomarker studies (1) to understand the neurobiology of individual differences in cognitive and brain aging; (2) to identify accelerated changes in brain structure and function that may be early markers of cognitive impairment and Alzheimer’s disease; (3) to track trajectories of biomarker changes that may provide insights into the pathophysiology of Alzheimer’s disease during its preclinical (asymptomatic) stage; (4) to investigate factors that modify brain-behavior associations in aging, including factors that promote the maintenance of cognitive health as well as those that increase risk for cognitive impairment; (5) to examine effects of sex, hormones, and other neurobiologic and cultural influences on individual differences in behavior, and the links between behavior and physical health across the lifespan.

List of Portfolio/Research Areas

  • Cognitive and brain aging;
  • Neuroimaging and fluid biomarkers of cognitive decline, impairment, and resilience.
  • Predictors and modifiers of cognitive and brain changes, including genetics, sex steroid hormones, and co-morbidities
  • Biologic underpinnings of “cognitive resilience” in carriers of the Apolipoprotein E (APOE) e4 risk allele for Alzheimer’s disease.

Selected Publications 2020-2024

2020

Han S, An Y, Carass A, Prince JL, Resnick SM. Longitudinal Analysis of Regional Cerebellum Volumes During Normal Aging. Neuroimage. 2020 Jun 24:117062. doi: 10.1016/j.neuroimage.2020.117062. PMID: 32592850. PMCID: PMC10683793

Armstrong NM, Dumitrescu L, Huang CW, An Y, Tanaka T, Hernandez D, Doshi J, Erus G, Davatzikos C, Ferrucci L, Resnick SM, Hohman TJ. Association of hippocampal volume polygenic predictor score with baseline and change in brain volumes and cognition among cognitively healthy older adults. Neurobiol Aging. 2020 May 21; 94:81-88. doi: 10.1016/j.neurobiolaging.2020.05.007. PMID: 32593031. PMCID: PMC8893954

Armstrong NM, An Y, Shin JJ, Williams OA, Doshi J, Erus G, Davatzikos C, Ferrucci L, Beason-Held LL, Resnick SM. Associations between cognitive and brain volume changes in cognitively normal older adults. Neuroimage. 2020 Aug 21; 223:117289. doi: 10.1016/j.neuroimage.2020.117289. PMID:32835822. PMCID: PMC9020590

Armstrong NM, Williams OA, Landman BA, Deal JA, Lin FR, Resnick SM. Association of Poorer Hearing with Longitudinal Change in Cerebral White Matter Microstructure. JAMA Otolaryngol Head Neck Surg. 2020 Sep 3:e202497. doi:10.1001/jamaoto.2020.2497. PMID: 32880621; PMCID: PMC7489397.

Tian Q, Studenski SA, Montero-Odasso M, Davatzikos C, Resnick SM, Ferrucci L. Cognitive and neuroimaging profiles of older adults with dual decline in memory and gait speed. Neurobiol Aging. 2020 Oct 9;97:49-55. oi: 10.1016/j.neurobiolaging.2020.10.002. PMID: 33152563

2021

Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, Espeland M, Masters C, Maruff P, Fripp J, Völzk H, Johnson SC, Morris JC, Albert MS, Miller MI, Bryan RN, Grabe HJ, Resnick SM, Wolk DA, Davatzikos C; iSTAGING consortium, the Preclinical AD consortium, the ADNI, and the CARDIA studies. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimers Dement. 2021 Jan;17(1):89-102. Doi: 10.1002/alz.12178. PMID: 32920988 PMCID: PMC7923395

Shafer AT, Beason-Held L, An Y, Williams OA, Huo Y, Landman BA, Caffo BS, Resnick SM. Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype. Neurobiol Aging. 2021; Aug; 104:10-23. Doi: 10.1016/j.neurobiolaging.2021.03.013. PMID: 33957555

Terracciano A, Bilgel M, Aschwanden D, Luchetti M, Stephan Y, Moghekar AR, Wong DF, Ferrucci L, Sutin AR, Resnick SM. Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis. Biol Psychiatry. 2021 Sep 3:S0006-3223(21)01566-3. doi: 10.1016/j.biopsych.2021.08.021. PMID: 34663503. PMCID: PMC8792161

Beason-Held LL, Fournier D, Shafer AT, Fabbri E, An Y, Huang CW, Bilgel M, Wong DF, Ferrucci L, Resnick SM. Disease Burden Affects Aging Brain Function. J Gerontol A Biol Sci Med Sci. 2021 Jul 30: glab218. doi: 10.1093/gerona/glab218. PMID: 34329447. PMCID: PMC9757056

Grober E, Wang C, Kitner-Triolo M, Lipton RB, Kawas C, Resnick SM. Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment. J Int Neuropsychol Soc. 2021 Mar 22:1-8. doi: 10.1017/S1355617721000291. PMID: 33745492; PMCID: PMC8455713.

Tian Q, Studenski SA, Montero-Odasso M, Davatzikos C, Resnick SM, Ferrucci L. Cognitive and neuroimaging profiles of older adults with dual decline in memory and gait speed. Neurobiol Aging. 2021 Jan; 97:49-55. doi: 10.1016/j.neurobiolaging.2020.10.002. PMID: 33152563.

Bilgel M, Bannerjee A, Shafer A, An Y, Resnick SM. Vascular risk is not associated with PET measures of Alzheimer's disease neuropathology among cognitively normal older adults. Neuroimage Rep. 2021 Dec;1(4):100068. doi: 10.1016/j.ynirp.2021.100068. Epub 2021 Nov 29. PMID: 34927122; PMCID: PMC8682073.

2022

Tian Q, Bilgel M, Moghekar AR, Ferrucci L, Resnick SM. Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults. J Alzheimer’s Dis. 2022 Feb 15. doi: 10.3233/JAD-210636. PMID: 35180111.

Wang X, Younan D, Millstein J, Petkus AJ, Garcia E, Beavers DP, Espeland MA, Chui HC, Resnick SM, Gatz M, Kaufman JD, Wellenius GA, Whitsel EA, Manson JE, Rapp SR, Chen JC. Association of improved air quality with lower dementia risk in older women. Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):e2107833119. doi: 10.1073/pnas.2107833119. PMID: 34983871; PMCID: PMC8764698.

Younan D, Wang X, Millstein J, Petkus AJ, Beavers DP, Espeland MA, Chui HC, Resnick SM, Gatz M, Kaufman JD, Wellenius GA, Whitsel EA, Manson JE, Rapp SR, Chen JC. Air quality improvement and cognitive decline in community-dwelling older women in the United States: A longitudinal cohort study. PLoS Med. 2022 Feb 3;19(2):e1003893. doi: 10.1371/journal.pmed.1003893. PMID: 35113870; PMCID: PMC8812844.

Shafer AT, Williams OA, Perez E, An Y, Landman BA, Ferrucci L, Resnick SM. Accelerated decline in white matter microstructure in subsequently impaired older adults and its relationship with cognitive decline. Brain Commun. 2022 Mar 1;4(2): fcac051. doi: 10.1093/braincomms/fcac051. eCollection 2022. PMID: 35356033 PMCID: PMC8963308

Wen J, Fu CHY, Tosun D, Veturi Y, Yang Z, Abdulkadir A, Mamourian E, Srinivasan D, Skampardoni I, Singh A, Nawani H, Bao J, Erus G, Shou H, Habes M, Doshi J, Varol E, Mackin RS, Sotiras A, Fan Y, Saykin AJ, Sheline YI, Shen L, Ritchie MD, Wolk DA, Albert M, Resnick SM, Davatzikos C; iSTAGING consortium, ADNI, BIOCARD, and BLSA. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients with Late-Life Depression. Jama Psychiatry 2022; 79(5):464-474. DOI: 10.1001/jamapsychiatry.2022.0020, PMID: 35262657. PMCID: PMC8908227

Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris JC, Albert MS, Bryan NR, Resnick SM, Nasrallah IM, Davatzikos C, Wolk DA; from the iSTAGING consortium; ADNI. Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. Brain Commun. 2022 May 7;4(3): fcac117. doi: 10.1093/braincomms/fcac117. eCollection 2022. PMID: 35611306 PMCID: PMC9123890

Bilgel M, Wong DF, Moghekar AR, Ferrucci L, Resnick SM; Alzheimer’s Disease Neuroimaging Initiative. Causal links among amyloid, tau, and neurodegeneration. Brain Commun. 2022 Jul 25;4(4): fcac193. doi: 10.1093/braincomms/fcac193. eCollection 2022. PMID: 35938073 PMCID: PMC9345312

Betthauser TJ, Bilgel M, Koscik RL, Jedynak BM, An Y, Kellett KA, Moghekar A, Jonaitis EM, Stone CK, Engelman CD, Asthana S, Christian BT, Wong DF, Albert M, Resnick SM, Johnson SC; Alzheimer’s Disease Neuroimaging Initiative. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain. 2022 Nov 21;145(11):4065-4079. doi: 10.1093/brain/awac213. PMID: 35856240 PMCID: PMC9679170

2023

Tian Q, An Y, Kitner-Triolo MH, Davatzikos C, Studenski SA, Ferrucci L, Resnick SM. Associations of Olfaction With Longitudinal Trajectories of Brain Volumes and Neuropsychological Function in Older Adults. Neurology. 2023 Feb 28;100(9):e964-e974. doi: 10.1212/WNL.0000000000201646. PMID: 36460474 PMCID: PMC9990434

Beason-Held LL, Kerley CI, Chaganti S, Moghekar A, Thambisetty M, Ferrucci L, Resnick SM, Landman BA. Health Conditions Associated with Alzheimer's Disease and Vascular Dementia. Ann Neurol. 2023 Apr;93(4):805-818. doi: 10.1002/ana.26584. PMID: 36571386

Walker KA, Duggan MR, Gong Z, Dark HE, Laporte JP, Faulkner ME, An Y, Lewis A, Moghekar AR, Resnick SM, Bouhrara M. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging. Ann Clin Transl Neurol. 2023 Mar;10(3):397-407. doi: 10.1002/acn3.51730. PMID: 36762407 PMCID: PMC10014005

Cooper CP, Shafer AT, Armstrong NM, An Y, Erus G, Davatzikos C, Ferrucci L, Rapp PR, Resnick SM. Associations of baseline and longitudinal change in cerebellum volume with age-related changes in verbal learning and memory. Neuroimage. 2023 May 15; 272:120048. doi: 10.1016/j.neuroimage.2023.120048. PMID: 36958620 Free PMC article.

Terracciano A, Walker K, An Y, Luchetti M, Stephan Y, Moghekar AR, Sutin AR, Ferrucci L, Resnick SM. The association between personality and plasma biomarkers of astrogliosis and neuronal injury. Neurobiol Aging. 2023 Aug; 128:65-73. doi: 10.1016/j.neurobiolaging.2023.04.011. PMID: 37210782 PMCID: PMC10247521

Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, Karikari TK, Blennow K, Zetterberg H, Jedynak BM, Thambisetty M, Ferrucci L, Resnick SM. Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid. Alzheimers Dement. 2023 Oct;19(10):4335-4345. doi: 10.1002/alz.13157. PMID: 37216632 PMCID: PMC10592628

Tian Q, Bilgel M, Walker KA, Moghekar AR, Fishbein KW, Spencer RG, Resnick SM, Ferrucci L. Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration. Alzheimers Dement. 2023 Oct;19(10):4436-4445. doi:10.1002/alz.13388. PMID: 37530130; PMCID: PMC10592411.

Archer DB, Schilling K, Shashikumar N, Jasodanand V, Moore EE, Pechman KR, Bilgel M, Beason-Held LL, An Y, Shafer A, Ferrucci L, Risacher SL, Gifford KA, Landman BA, Jefferson AL, Saykin AJ, Resnick SM, Hohman TJ; Alzheimer's Disease Neuroimaging Initiative. Leveraging longitudinal diffusion MRI data to quantify differences in white matter microstructural decline in normal and abnormal aging. Alzheimers Dement (Amst). 2023 Oct-Dec. Alzheimers Dement (Amst). 2023 Sep 29;15(4):e12468. doi: 10.1002/dad2.12468. PMID: 37780863; PMCID: PMC10540270.

Chang K, Ling JP, Redding-Ochoa J, An Y, Li L, Dean SA, Blanchard TG, Pylyukh T, Barrett A, Irwin KE, Moghekar A, Resnick SM, Wong PC, Troncoso JC. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline. Acta Neuropathol. 2023 Dec 22;147(1):4. doi:10.1007/s00401-023-02653-2. PMID: 38133681

2024

Dark HE, Paterson C, Daya GN, Peng Z, Duggan MR, Bilgel M, An Y, Moghekar A, Davatzikos C, Resnick SM, Loupy K, Simpson M, Candia J, Mosley T, Coresh J, Palta P, Ferrucci L, Shapiro A, Williams SA, Walker KA. Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk. Ann Neurol. 2024 Feb;95(2):260-273. doi: 10.1002/ana.26817. PMID:37801487; PMCID: PMC10842994.

Tian Q, Lee PR, Yang Q, Moore AZ, Landman BA, Resnick SM, Ferrucci L. The mediation roles of intermuscular fat and inflammation in muscle mitochondrial associations with cognition and mobility. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):138-148. doi: 10.1002/jcsm.13413. PMID: 38116708; PMCID: PMC10834332.

Dark HE, An Y, Duggan MR, Joynes C, Davatzikos C, Erus G, Lewis A, Moghekar AR, Resnick SM, Walker KA. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline. Alzheimers Res Ther. 2024 Apr 30;16(1):94. doi: 10.1186/s13195-024-01459-y. PMID: 38689358; PMCID: PMC11059745.